Glycosyltransferases as targets for inhibition of cell wall synthesis in M. tuberculosis and M. avium

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 106-121

  Maddry, J A ^a   Suling, W J ^a   Reynolds, R C ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINOSE; ETHAMBUTOL; GLYCOSYLTRANSFERASE; TUBERCULOSTATIC AGENT;

BACTERIAL CELL WALL; CONFERENCE PAPER; DRUG DESIGN; DRUG TARGETING; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; ETHAMBUTOL; GLYCOSYLTRANSFERASES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM TUBERCULOSIS; PHOSPHOLIPIDS;

EID: 0029874716     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80211-7     Document Type: Article

References (25)

1. Avigad, G. & Englard, S. (1975), 5-Keto-D-fructose and its phosphate esters. Methods Enzymol., 41, 84-90.
2. Baker, C.N., Banerjee, S.N. & Tenover, F.C. (1994), Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of Gram-negative bacteria. J. Clin. Microbiol., 32, 1261-1267.
3. Banerjee, A., Dubnau, E., Quémard, A., Balasubramanian, V., Um, K.S., Wilson, T., Collins, D., de Lisle, G. & Jacobs, W.R., Jr. (1994), inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science, 263, 227-230.
4. Blessington, B. & Beiraghi, A. (1990), Study of the stereochemistry of ethambutol using chiral liquid chromatography and synthesis. J. Chromatogr., 522, 195-203.
5. Brennan, P.J. (1989), Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev. Infect. Dis., 11, S420-S430.
6. 13C NMR analyses. J. Biol. Chem., 265, 6734-6743.
7. David, H.L. (1981), Basis for lack of drug susceptibility of atypical mycobacteria. Rev. Infect. Dis., 3, 878-884.
8. Dessen, A., Quémard, A., Blanchard, J.S., Jacobs, W.R., Jr. & Sacchettini, J.C. (1995), Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science, 267, 1638-1641.
9. Frische, K. & Schmidt, R.R. (1994), Glycal-1-ylmethyl-phosphonates - precursors of glycosyl transferase inhibitors. Liebigs Ann. Chem., 297-303.
10. Hindsgaul, O., Kaur, K.J., Srivastava, G., Blaszczyk-Thurin, M., Crawley, S.C., Heerze, L.D. & Palcic, M.M. (1991), Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases. J. Biol Chem., 266, 17858-17862.
11. Leysen, D.C., Haemers, A., Blanchaert, L., Van Assche, I., Bollaert, W., Schoenmaekers, K. & Pattyn, S.R. (1987), The mycobacterial cell wall as target for antimycobacterial drugs. Farm. Ed. Sci., 42, 823-831.
12. Rastogi, N., Goh, K.S. & David, H.L. (1990), Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob. Agents Chemother., 34, 759-764.
13. Rastogi, N., Goh, K.S. & Labrousse, V. (1992), Activity of clarithromycin with those of other drugs against Mycobacterium paratuberculosis and further enhancement of its extracellular and intracellular activities by ethambutol. Antimicrob. Agents Chemother., 36, 2843-2846.
14. th Forum in Microbiology" (N. Rastogi). Res. Microbiol., 144, 133-143.
15. Schachter, H. & Roseman, S. (1980), Mammalian glycosyltransferases, in "The Biochemistry of Glycoproteins and Proteoglycans" (W. Lennarz) (Ch. 3). Plenum Press, New York.
16. Sensi, P. (1989), Approaches to the development of new antituberculosis drugs. Rev. Infect. Dis., 11, S467-S470.
17. Shepherd, R.G., Baughn, C., Cantrall, M.L., Goodstein, B., Thomas, J.P. & Wilkinson, R.G. (1966), Structure-activity studies leading to ethambutol, a new type of antituberculosis compound. Ann. N. Y. Acad. Sci., 135, 680-1120.
18. Silve, G., Valero-Guillen, P., Qumard, A., Dupont, M.-A., Daffe, M. & Laneelle, G. (1993), Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug. Antimicrob. Agents Chemother., 37, 1536-1538.
19. Singh, S. & Hogan, S.E. (1994), Isolation and characterization of sugar nucleotides from Mycobacterium smegmatis. Microbios., 77, 217-222.
20. Sinnott, M.L. (1984), Glycosyl transfer. New Compr. Biochem., 6, 389-431.
21. Takayama, K., Armstrong, E.L., Kunugi, K.A. & Kilburn, J.O. (1979), Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob. Agents Chemother., 16, 240-242.
22. Wallace, R.J., Jr., Nash, D.R., Steel, L.C. & Steingrube, V. (1986), Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J. Clin. Microbiol., 24, 976-981.
23. Wilkinson, R.G., Shepherd, R.G., Thomas, J.P. & Baughn, C. (1961), Stereospecificity in a new type of synthetic antituberculosis agent. J. Am. Chem. Soc., 83, 2212-2213.
24. Wolucka, B.A., McNeil, M.R., de Hoffmann, E., Chojnacki, T. & Brennan, P.J. (1994), Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem., 269, 23328-2335.
25. Young, D.B. (1994), Strategies for new drug development, in "Tuberculosis: Pathogenesis, Protection, and Control" (B.R. Bloom) (pp. 559-567). American Society for Microbiology Press, Washington, D.C.